Introduction
Introduction

'Cancer stem-cells' or 'tumour-initiating cells' have been defined, by analogy with normal stem-cells, as cells that have the capacity to self-renew, that is to divide and generate more 'cancer stemcells' as well as to differentiate into the variety of neoplastic cells found in tumours [1, 2] The identification and isolation of tumour initiating cells is important because they represent potential candidates responsible for tumour chemoresistance and relapse and could be the cell of origin of tumours. Several approaches have been explored to identify and isolate cancer stem-cells. One of these methods is side population (SP) analysis. This analysis is based on a technique described by
. [3] [4] . SP analysis has been commonly used as one of the methods for enriching for 'tumour-initiating cells' in cancer cell lines and primary tumour cultures [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Others have shown in other systems that the SP phenotype correlates with a distinct cell population enriched for primitive and undifferentiated cells [16] .
There is evidence that some acute and chronic leukaemia and some solid tumours may contain 'tumour-initiating cells' and a cell hierarchy similar of that observed in normal tissues from which a tumour arises [7, 17, 18] [19] .
. This view, inspired by the unique capacity of the normal haematopoietic stem-cells to restore long-term haematopoiesis in myeloablated mice, postulates that most cells in a tumour lack self-renewal potential and, hence, do not contribute significantly to tumour perpetuation. Although research is rapidly advancing in this field, to our knowledge, there are no published reports examining the presence and/or role of SP cells in non-Hodgkin lymphomas and only rare papers address the issue of tumour initiating cells in lymphomas
Non-Hodgkin lymphomas have been increasing in incidence over the last three decades [20, 21] 
and are a heterogeneous group of lymphoid tumours, more than 80% of which are of B-cell lineage. One type of B-cell non-Hodgkin lymphoma with a poor prognosis is mantle cell lymphoma (MCL). MCL is distinctive B-cell non-Hodgkin lymphoma characterized by CD5 and cyclin D1 expression and the t(11;14)(q13;q32). In addition to involvement of lymph nodes, the spleen, bone marrow and gastrointestinal tract are commonly involved and approximately 25% of patients have a leukemic phase. There is also a blastoid variant (BV) of MCL, representing 10-20% of cases, that is particularly aggressive clinically and has high-grade histological features.
Recently, Ford et al. [22] 
have established an IL-14␣ ϫ c-Myc double transgenic (DTG)/MCL-BV model. The animals, referred to as DTG mice, develop an aggressive, monoclonal B-cell lymphoma, positive for CD5 and cyclin D1 with features consistent with human MCL-BV [22]. Using this model, we found that DTG lymphoma cell lines have a surprisingly large SP fraction (up to 6%) and that this subpopulation is enriched for cells with at least some features of 'tumour-initiating cells'. Our data support the interpretation that the DTG SP fraction contains a cell population essential for tumour maintenance and systemic dissemination and lends support to the concept that 'tumour-initiating cells' occur in lymphomas.
Material and methods
Cell lines
Flow cytometry immunophenotyping
In vivo tumorigenicity assay
To determine if the SP fraction is enriched with tumour-initiating cells and whether tumorigenicity differs between SP and non-SP cells, in vivo experiments were performed in accord with the institutional guidelines for the use of laboratory animals. After isolation of the SP and non-SP cell fractions, sorted cells were washed twice with PBS and various numbers
Immunohistochemistry
Immunohistochemical methods were used as previously described [30] 
Immunoglobulin gene rearrangements
Polymerase chain reaction (PCR) methods to assess for immunoglobulin gene rearrangements were performed with DNA extracted from DTG SP, non-SP and total (non-fractionated) DTG cells using the DNeasy Tissue kit (Qiagen, Valencia, CA, USA)
. The primers used have been previously described [22] . The PCR products were analysed by electrophoresis using 1.2% agarose gels. (Fig. 3A) .
Reverse transcriptase-polymerase chain reaction (RT-PCR) and stem cell PCR array
DTG SP cells and non-SP cells are clonal cell populations
IgH gene rearrangement studies performed on DNA obtained from the SP, non-SP and total DTG cell fractions, showed monoclonal gene rearrangements (Fig. S1). The monoclonal bands detected in the three samples had the same size supporting the interpretation that they are clonally related. Expression of c-Myc was also determined in SP and non-SP cells using RT-PCR. High levels of expression of c-Myc were detected in both cell fractions (Fig. S1).
DTG SP cells show higher expression levels of BCL-2 protein than non-SP cells
These findings suggest that the DTG non-SP cell fraction is less effective in regenerating SP cells than the SP cell fraction. In addition, it is possible that few SP cells 'contaminate' the non-SP fraction in each sorting; this may explain the decreased ratio of SP cells to non-SP cells seen in each successive sort of non-SP cells. In addition, we examined differences in cell viability between serially-sorted DTG SP and non-SP cells. To examine cell viability differences, equal numbers of SP and non-SP cells were cultured up to three extra weeks after each serial cell sorting at 2, 4 and 8 weeks. Cell viability was analysed by trypan blue exclusion at 1, 2 and 3 weeks after each sorting. In all these experiments, the non-SP cell fraction demonstrated a progressive and substantial decrease in cell viability over time, in comparison with the SP fraction (Fig. 3B).
To determine if the differences seen in cell viability were, at least in part, due to Hoechst 33342 toxicity, we stained 10 ϫ 10 6 (Fig. S2) . (Fig. 3C) indicating that the SP cell fraction is more clonogenic than non-SP. (Fig. 3D) (Fig. 4D) .
DTG cells with Hoechst 33342 at a final concentration of 5 g/ml (37ЊC for 1.5 hrs), performed the SP analysis procedure but without cell sorting (mock analysis), and cultured the cells for 10 days. As a control, the same number of DTG cells were incubated with 5 g/ml of sterile PBS, SP analysis was performed (without sorting) and cells were cultured for 10 days. Initially, a decrease in the cell numbers is seen in both samples
Although an initial larger decrease in the total number of viable cells was seen in the sample exposed to Hoechst 33342 compared with control, a significant recovery in cell growth was seen in both samples after day 5 and no differences in cell numbers were seen at day 8 (Fig. S1). These results indicate that although Hoechst 33342 is toxic, the cells fully recover from the effects of the dye and from SP analysis after 7 days in culture. Therefore, Hoechst 33342 toxicity cannot explain the differences in cell viability observed between DTG SP and non-SP cells when cultured for more than 1 week.
DTG SP cells have more clonogenic ability than non-SP cells
To investigate differences in clonogenicity ability between DTG SP and non-SP cells, we assessed colony formation ability using an in vitro methylcellulose colony-forming assay. A total of 1 ϫ 10 3 sorted DTG SP and non SP-cells were cultured in methylcellulose for 10 days. DTG SP cells formed a greater number of colonies than the non-SP cells (35% for SP cells and 11.8% for non-SP cells, [P Ͻ 0.004]) at 10 days in culture
DTG SP cells are enriched with cells in S phase of the cell cycle
. No differences in the distribution of cells in various phases of the cell cycle were seen between non-SP cells and the non-sorted DTG cells.
DTG SP cells are more tumorigenic than the non-SP cells
Morphological evaluation of the DTG SP derived and non-SP derived lymphomas showed that both reproduced the blastoid histological appearance and the immunophenotypic characteristics of the primary lymphomas, being positive for B220, CD5
and cyclin D1 (Fig. 4B) [22] . However, some differences between DTG SP and non-SP lymphomas were noted. [31] [32] [33] [34] [35] . It also has been used recently to isolate and characterize 'tumour-initiating cells' from several types of cultured cancer cell lines [5, 6, [12] [13] [14] [15] . (Fig. S3) . However, we think that, at least in part, the higher SP percentage may be related to the fact that these DTG lymphomas are highly aggressive and rapidly fatal and that the DTG cell lines also have a very high proliferation rate with a duplication time of [16] [17] [18] hrs. 
Clusters of neoplastic cells were seen in several organs including, liver (intrasinusoidal and portal spaces), pancreas (perivascular), spleen (red pulp) and bone marrow in mice injected with the SP fraction (Fig. 5). By contrast, there was much less systemic dissemination in mice injected with non-SP cells. For example, although liver involvement was observed in some mice injected
Fig. 3 Self renewal, clonogenic ability and cell cycle properties of DTG SP cells. (A) To compare in vitro self-renewal capacity, sorted DTG SP and non-SP cells were cultured separately. Both subpopulations were re-stained with Hoechst 33342, and serially sorted again at 2, 4, 6 and 8 weeks and the proportion of SP cells quantified at the times as shown in the schematic diagram (upper panel). In each sorting, DTG SP cells were able to repopulate both SP and non-SP cells with an increased ratio of SP to non-SP (up to 13.53% SP cells at 8 weeks). Each successive sort of non-SP cells demonstrated predominantly non-SP cells with a progressively decreased ratio of SP to non-SP (0.73% SP cells at 8 weeks). (B) To compare cell viability between the DTG SP and non-SP fractions in culture, SP and non-SP cells were separately cultured under the same culture conditions up to three extra weeks after each serial sorting at 2, 4, 6 and 8 weeks. Cell viability was analysed by tryphan blue exclusion in duplicate at 1, 2 and 3 weeks. Cell viability data of the DTG SP and non-SP fractions sorted at 4 weeks and maintained in culture up
with non-SP cells involvement was usually minimal in the form of scattered single cells within sinusoids unlike the large cell clusters and/or portal involvement observed in mice injected with SP cells. Another histological difference was that non-SP derived lymphomas demonstrated more extensive tumour necrosis (estimated ~30-40%) compared with SP-derived lymphomas (~5%) (Fig. 5). SP re-analysis of lymphoma cell suspensions obtained from the DTG SP-and non-SP-derived tumours showed that the SP-derived tumours contained more than two-fold higher number of SP cells than non-SPderived tumours. These data suggest that the DTG SP fraction is more tumorigenic resulting in a greater tumour burden than the non-SP fraction in mice. The presence of extensive tumour necrosis in mouse tumours derived from non-SP cells suggests that the non-SP fraction is incapable of sustaining tumour growth for a prolonged period of time. In aggregate, these results suggest that the DTG SP population contains a subset of cells more capable of tumour maintenance and systemic dissemination.
Discussion
Since its initial application in the analysis of bone marrow haematopoietic stem-cells, the SP technique has been adapted to identify putative stem-cells in multiple tissues
In this work, using a recently described IL-14␣ ϫ c-Myc DTG/MCL-BV murine model, that closely simulates human MCL [22], we found that DTG lymphoma cell lines have a surprisingly large SP fraction (up to 6%). The explanation for why DTG cell lines have a higher SP percentage than other lymphoma cell lines that we have examined is not clear to us at this time
Because of their high percentage of SP cells, we used DTG cell lines to characterize the biological and molecular features of the
SP cells and to address whether these cells have features of 'tumour-initiating cells'.
Here proliferation [38] . It has been shown that telomerase activity appears to correlate with self-renewal capacity and is reduced as haematopoietic stem cells differentiate to multipotent progenitors [39] . Our data are consistent with other studies that found higher expression of human telomerase reverse transcriptase in SP in comparison with non-SP fractions [6, 40] . [12-15, 42, 43] .
It has been claimed that some of these observed differences are attributable to Hoechst 33342 toxicity [44] . [3, 5, [12] [13] [14] [15] 
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